Small particles of glass are to blame for the recall of a widely used fluticasone nasal spray that treats symptoms of hay fever in children. The nasal spray, known by its brand name Fluticasone ...

Please provide your email address to receive an email when new articles are posted on . The Exhalation Delivery System reaches inflamed areas of the nasal cavity and sinuses that other sprays miss.

LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug ...

SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, ...

SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, ...

(Washington-AP) February 22, 2006 - Some people with seasonal and chronic allergies could now have a cheaper alternative to treat their symptoms. Regulators have approved the first generic version of ...

Please provide your email address to receive an email when new articles are posted on . An exhalation delivery system that uses fluticasone propionate nasal spray reduced the symptoms of chronic ...

Credit: Getty Images. A PDUFA target date of December 16, 2023 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...

Within an hour, a single dose of a combination antihistamine that consists of loratadine and pseudoephedrine (Claritin D) delivers more than twice the rhinitis relief as a fluticasone nasal spray ...

March 14, 2006 — The US Food and Drug Administration (FDA) has approved a pressurized metered-dose inhaler (pMDI) formulation of flunisolide for the maintenance treatment of asthma in patients aged 6 ...